Pura Vida Investments’s Merck MRK Stock Holding History

Pura Vida Investments’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-136,240	Closed	-$8.33M	–	88
2017 Q2	$8.33M	Buy	+136,240	New	+$8.29M	3.31%	8

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Pura Vida Investments's MRK Position: Q1 2022 in Review

Pura Vida Investments sold out of Merck (MRK) in Q1 2022, closing a stake of 24,246 shares — an estimated $1.86M sold.

Pura Vida Investments first reported a position in MRK in Q2 2017 and held it in 7 quarters. The position peaked at $9.9M in Q3 2017. 2,953 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

Pura Vida Investments reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
Pura Vida Investments sold 24,246 Merck shares in Q1 2022, an estimated $1.86M.
Pura Vida Investments first reported a position in Merck in Q2 2017 and held it in 7 quarters.
Pura Vida Investments's Merck position peaked at $9.9M in Q3 2017.
2,953 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.